Spec. dr med. Jelica Bjekić Macut

Interna medicina

Endokrinologija

Endokrinologija

Beograd

MD Clinic

• Srpski

• Engleski

Medicinski fakultet Univerziteta u Beogradu

od 1982. do 1989.

Integrisane akademske studije

Medicinski fakultet Univerziteta u Beogradu

od 1992. do 1996.

Specijalizacija interne medicine

Medicinski fakultet Univerziteta u Beogradu

od 1992. do 1996.

Subspecijalizacija endokrinologije

Medicinski fakultet Univerziteta u Beogradu

do 2001.

Magistar medicinskih nauka

Medicinski fakultet Univerziteta u Beogradu

do 2011.

Specijalista uže specijalizacije endokrinologije

Medicinski fakultet Univerziteta u Beogradu

do 2011.

Doktor medicinskih nauka

Interna klinika KBC Bežanijska kosa

do 1996.

Specijalista interne medicine - endokrinologije

KBC Bežanijska kosa

od 2003. do 2010.

Načelnik Odeljenja endokrinologije

KBC Bežanijska kosa

od 2013. do 2014.

Načelnik Poliklinike

KBC Bežanijska kosa

od 2014.

Načelnik Odeljenja endokrinologije

Srspko lekarsko društvo

Član - Endokrinološka sekcija

European Society of Endocrinology

Član.

Endocrine Society (USA)

Član.

European Thyroid Association

Član.

Srpsko društvo za reproduktivnu endokrinologiju

Sekretar.

Organizacioni odbor 1, 2. i 3. International Symposium on Advances in PCOS and Women’s Health, Beograd 2012, 2016. i 2020.godine

Član.

Organizacioni odbor 5. i 6. Kongresa endokrinologa Srbije, Beograd 2016. i 2018.godine

Član.

Organizacioni odbor 1, 2. i 3. Belgrade Masterclass in Clinical Endocrinology, Diabetes and Metabolism, Beograd 2019, 2020. i 2021. godine

Član.

Maturitas

do 2021.

The interplay between metabolic dysregulations and non-alcoholic fatty liver disease in women after menopause.

Curr Pharm Des

do 2019.

Polycystic Ovary Syndrome: A Contemporary Clinical Approach - Koautor

J Endocrinol Invest

The effect of metformin and myoinositol on metabolic outcomes in women with polycystic ovary syndrome: role of body mass and adiponectin in a randomized controlled trial. - Koautor.

Nutrients

do 2021.

A. Mediterranean Diet and Type 2 Diabetes Mellitus: A Perpetual Inspiration for the Scientific World. - Koautor.

Oxid Med Cell Longev

do 2021.

Development and Validation of a Multivariable Predictive Model for Mortality of COVID-19 Patients Demanding High Oxygen Flow at Admission to ICU: AIDA Score.

Front Endocrinol (Lausanne)

do 2019.

Metabolic Perspectives for Non-classical Congenital Adrenal Hyperplasia With Relation to the Classical Form of the Disease. - Koautor.

Front Horm Res

do 2019.

Androgen-Secreting Ovarian Tumors - Koautor.

Diabetes Ther

do 2018.

Clinical Benefit of Basal Insulin Analogue Treatment in Persons with Type 2 Diabetes Inadequately Controlled on Prior Insulin Therapy: A Prospective, Noninterventional, Multicenter Study

Hormones (Athens)

do 2018.

A decade in female reproduction: an endocrine view of the past and into the future.

J Pediatr Endocrinol Metab

do 2018.

The association of hs-CRP and fibrinogen with anthropometric and lipid parameters in non-obese adolescent girls with polycystic ovary syndrome.

Endokrynol Pol

do 2018.

Glutathione S-transferase (GST) polymorphism could be an early marker in the development of polycystic ovary syndrome (PCOS) - an insight from non-obese and non-insulin resistant adolescents.

Eur J Endocrinol

do 2017.

MANAGEMENT OF ENDOCRINE DISEASE: Polycystic ovary syndrome and nonalcoholic fatty liver disease.

Diabetes Res Clin Pract

do 2017.

Insulin and the polycystic ovary syndrome.

J Med Biochem

do 2016.

Cortisol Response to Low-dose (1 µg) ACTH Stimulation for the Prediction of Outcome in Patients with Systemic Inflammatory Response Syndrome.

Eur J Endocrinol

do 2016.

Lipid accumulation product as a marker of cardiometabolic susceptibility in women with different phenotypes of polycystic ovary syndrome.

Hum Reprod

do 2016.

Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome.

Hormones (Athens)

do 2015.

Associations of menstrual cycle irregularities with age, obesity and phenotype in patients with polycystic ovary syndrome.

Int J Endocrinol

do 2015.

Predictors of subclinical cardiovascular disease in women with polycystic ovary syndrome: interrelationship of dyslipidemia and arterial blood pressure.

Endocrine

do 2015.

Cardiac fatty acid uptake and metabolism in the rat model of polycystic ovary syndrome.

J Endocrinol Invest

do 2015.

Cardiovascular risk factors and events in women with androgen excess.

Mol Cell Endocrinol

do 2015.

Possible involvement of glucocorticoids in 5αdihydrotestosterone-induced PCOS-like metabolic disturbances in the rat visceral adipose tissue.

Exp Clin Endocrinol Diabetes

do 2011.

Insulin resistance in non-obese women with polycystic ovary syndrome: relation to byproducts of oxidative stress.

Endocrine

do 2013.

Age, body mass index, and serum level of DHEA-S can predict glucocorticoid receptor function in women with polycystic ovary syndrome.

Can J Physiol Pharmacol

do 2008.

Lipid and lipoprotein profile in women with polycystic ovary syndrome.

Eur J Endocrinol

do 2006.

Oxidised low-density lipoprotein concentration - early marker of an altered lipid metabolism in young women with PCOS.